Troppo Caldo! babyLance and SurgiLance Very Hot in Italian Medical Product Markets

New Distribution Partnership with Haemoclub International SLR Already Reporting Considerable Interest in Italy for MediPurpose’s Fingersticks and Infant Heelsticks
 
 
Spread the Word
Listed Under

Tags:
Medical Device
Medical Product
Italy
Italian
Distribution
Distributor
Nurse
Nursing
Heelstick
Fingerstick

Industrys:
Business
Health
Medical

Location:
Duluth - Georgia - US

July 6, 2011 - PRLog -- ROME and ATLANTA – MediPurpose, a master distributor and manufacturer of medical products, recently announced Haemoclub International SLR as its newest Italian medical product distribution partner for its babyLance infant heel incision device and SurgiLance safety lancet brands.

According to Haemoclub International’s Patrick Vito, MediPurpose blood collection devices are generating significant attention at several hospitals and healthcare facilities in Italy where nurses and clinicians have been testing the medical products.

In particular, Vito is confident that both models of babyLance--the Preemie (BLP) and the Newborn (BLN)--and the SurgiLance SLN100 are positioned to become highly competitive players in the Italian medical product market.
   
Designed expressly for infants, babyLance is an ideal device for drawing blood from the heels of infants. Likewise, the SurgiLance SLN100’s needle--with 1.0mm depth of penetration--is an appropriate complement for pediatric fingersticks.

Italy has the third-largest medical device market in Europe, according to Espicom Business Intelligence. The Italian market for medical equipment and supplies is valued at US $8.0 billion, which is equal to US $133 per capita.

According to MediPurpose President Randy Prather, who oversees the company’s global blood collection and analytics division, the timing is ripe for Italian and other European healthcare facilities to adopt these products.

“Changes in international regulatory requirements now mandate the use of single-use fingersticks,” said Prather. “This is very similar to the requirements of the 2001 Safety Needle Act in the United States, and we anticipate the market will continue to expand as a result.”

Both babyLance and SurgiLance have received 510(k) clearances from the U.S. Food and Drug Administration (FDA). The FDA clearances demonstrate MediPurpose’s commitment to ensuring the highest standards of safety for both patient and healthcare provider.

More information about babyLance and SurgiLance--including demonstration videos and no-cost product sample requests--is available at http://www.medipurpose.com/products .

# # #

ABOUT MEDIPURPOSE
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance heel incision device, SurgiLance safety lancet and MediPlus advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com .
End
Source:Derek Rudnak | MediPurpose®
Email:***@medipurpose.com Email Verified
Phone:+1-770-448-9493
Zip:30097
Tags:Medical Device, Medical Product, Italy, Italian, Distribution, Distributor, Nurse, Nursing, Heelstick, Fingerstick
Industry:Business, Health, Medical
Location:Duluth - Georgia - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
MediPurpose™ PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share